PAGNINI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.191
EU - Europa 3.076
AS - Asia 2.138
SA - Sud America 294
AF - Africa 62
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.141
RU - Federazione Russa 1.080
IT - Italia 651
SG - Singapore 596
CN - Cina 500
PL - Polonia 408
HK - Hong Kong 331
IE - Irlanda 272
BR - Brasile 240
SE - Svezia 226
VN - Vietnam 221
KR - Corea 172
IN - India 92
FI - Finlandia 86
FR - Francia 86
GB - Regno Unito 79
DE - Germania 71
JO - Giordania 48
AU - Australia 40
BD - Bangladesh 37
CA - Canada 29
JP - Giappone 27
AR - Argentina 23
ID - Indonesia 23
UA - Ucraina 21
AT - Austria 20
TR - Turchia 20
ES - Italia 19
CH - Svizzera 17
IQ - Iraq 16
CI - Costa d'Avorio 15
NL - Olanda 14
ZA - Sudafrica 14
MX - Messico 13
BE - Belgio 9
AZ - Azerbaigian 7
EC - Ecuador 7
MA - Marocco 7
NG - Nigeria 7
PY - Paraguay 7
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CL - Cile 5
SC - Seychelles 5
VE - Venezuela 5
EG - Egitto 4
IL - Israele 4
KZ - Kazakistan 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
BO - Bolivia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
IR - Iran 3
KE - Kenya 3
TN - Tunisia 3
BG - Bulgaria 2
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
PA - Panama 2
PH - Filippine 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.802
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.088
Ashburn 631
Fairfield 438
Singapore 429
Warsaw 406
Hong Kong 277
Dublin 266
Chandler 246
Dallas 205
Woodbridge 186
Cambridge 180
Seoul 171
Seattle 170
Houston 161
Beijing 160
Wilmington 151
Milan 146
San Jose 119
Lawrence 101
The Dalles 96
Altamura 95
Los Angeles 88
Ann Arbor 83
Princeton 79
Ho Chi Minh City 73
Hefei 66
Buffalo 60
Lauterbourg 60
Medford 52
Hanoi 49
Moscow 44
London 41
New York 40
Florence 39
Mumbai 39
Rome 39
Boston 37
Munich 37
Melbourne 34
Shanghai 33
San Diego 32
Clifton 25
Tokyo 25
Council Bluffs 24
Helsinki 24
Pune 24
Boardman 21
São Paulo 19
Vienna 19
Jacksonville 18
Kent 18
Jakarta 17
Abidjan 15
Bern 15
Figino 15
Turku 15
Chennai 14
Naples 14
Redondo Beach 14
Norwalk 13
Chicago 12
Da Nang 12
Falls Church 12
Orem 12
Toronto 12
Turin 12
Miano 11
Palermo 11
Paris 11
Bologna 10
Hillsboro 10
Barcelona 9
Johannesburg 9
San Francisco 9
Ankara 8
Brussels 8
Dong Ket 8
Genoa 8
Izmir 8
Bari 7
Brooklyn 7
Erbil 7
Guangzhou 7
Phoenix 7
A Coruña 6
Abuja 6
Frankfurt am Main 6
Rio de Janeiro 6
Tashkent 6
Thái Bình 6
Trieste 6
Venice 6
Yubileyny 6
Amsterdam 5
Atlanta 5
Baku 5
Brescia 5
Cagliari 5
Campinas 5
Columbus 5
Totale 7.412
Salva come PNG Salva come JPEG
Nome #
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 299
biologic therapy in children with enthesitis-related arthritis the fist year after disease onset 289
The intestinal microbiota in enthesitis-related arthitis 275
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 241
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 236
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 235
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports 232
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 227
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 224
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 213
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 208
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 206
Oral clonidine provocative test in the diagnosis of growth hormone deficiency in childhood: should we make the timing uniform? 204
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 189
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 188
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 184
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 167
The off-label use of anakinra in pediatric systemic autoinflammatory diseases 167
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 164
Clinical features and outcome of Cogan syndrome. 163
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity? 161
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 160
Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review 159
Ocular involvement in monogenic autoinflammatory disease: A systematic literature review 159
STAT3-confusion-of-function: Beyond the loss and gain dualism 154
Distal extremity pain as a presenting feature of Fabry's disease. 153
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 153
Sequential MR angiography in childhood primary angiitis of the CNS. 153
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 153
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 152
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 152
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 151
Acute hemorrhagic edema of infancy: 20‐year experience from an Italian tertiary referral center 150
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 149
Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment? 149
Cervical arthritis as early manifestation of enthesitis-related arthritis complicated by uveitis 148
 A Rare Case of Neonatal Antiphospholipid Syndrome 148
CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection 146
Development and retrospective validation of the juvenile spondyloarthritis disease activity index. 145
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 144
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series 143
Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey 140
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis. 140
Utility of magnetic resonance imaging when following up sacroiliitis in enthesitis-related arthritis. 140
Treatment strategies for childhood noninfectious chronic uveitis: an update. 138
Final height in females and males with precocious puberty after GnRHa treatment 138
 Possible Correlation Between Congenital Heart Block and Autoimmune Hearing Loss 135
Cogan Syndrome: a rare but severe vasculitis in pediatric age 129
Oral clonidine provocative test in the diagnosis of growth hormone deficiency (GHD) in childhood: should we make the timing uniform? 129
Circulating levels of vaspin and omentin, two novel adipokines, in juvenile idiopathic arthritis 129
BONE STATUS OF CHILDREN BORN FROM MOTHERS WITH AUTOIMMUNE DISEASES TREATED DURING PREGNANCY WITH LOW MOLECULAR WEIGHT HEPARIN AND/OR PREDNISONE 128
Biological drugs in paediatric COVID-19 infection: what patients, which drug, how much and how long 128
Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms 126
Cutaneous polyarteritis nodosa and common variable immunodeficiency: a previously unreported association. 124
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. 123
Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments 121
Kawasaki disease 2013: Clinical cases and new issues 118
Pathogenesis of juvenile idiopathic arthritis: A review of the possible role of different synovial fluid T lymphocyte subsets 118
Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure 114
Distal limb pain as presenting feature of Fabry disease. 114
What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis? 110
Pathogenesis of Juvenile Idiopathic Arthritis: A Review of the Possible Role of Different Synovial Fluid T Lymphocyte Subsets 107
Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. 102
Increased percentages of tumor necrosisfactor-alpha+/interferon-gamma+ lymphocytes and calprotectin+/tumor necrosisfactor-alpha+ monocytes in patients with acute Kawasaki disease 93
Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis. 92
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features 82
Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation. 80
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease. 79
Usefulness of autoantibodies against inner ear antigens for the diagnosis 78
null 72
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study 67
Calcinosis Cutis and Delayed‐Onset Myositis in a Case of Suspected Localized Scleroderma: A Diagnostic and Therapeutic Challenge 10
Baricitinib for juvenile idiopathic arthritis: A monocentric case series 9
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study 9
Totale 10.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022518 4 79 69 34 8 12 15 45 17 17 68 150
2022/20231.238 111 276 58 83 72 214 167 59 127 11 31 29
2023/2024456 14 44 71 18 36 109 24 82 12 18 21 7
2024/20253.074 121 308 167 455 950 408 29 204 129 60 123 120
2025/20263.541 361 532 314 295 385 155 392 157 192 185 112 461
2026/20278 8 0 0 0 0 0 0 0 0 0 0 0
Totale 10.915